IFNβ was integrated into the NPC-GPOH treatment concept after a child with relapsing NPC and multiple intracerebral metastases went into complete remission being treated exclusively with IFNβ [10]. The gene discussed is IFNB1; the disease is nasopharyngeal carcinoma.